(kat) VIBRIO etc.pdf

download (kat) VIBRIO etc.pdf

of 137

Transcript of (kat) VIBRIO etc.pdf

  • KATHLEEN ROSS S. CALIGAGAN, MD, FPSNM

    VIBRIOCAMPYLOBACTER

    HELICOBACTER

  • TERMINOLOGY

    Halophilic requiring the presence of NaCl to grow

    Thermophilic can live in high temp (up to 420C)

    Microaerophilic require oxygen in concentration lower than room air (8.5 pH)

    Anaerobic do not require oxygen

    Facultative anaerobic may or may not require oxygen

    Obligate intracellular pathogens that must live within the host cell (do not grow on artificial cultures, instead,

    they should be inoculated into embryonated chicken

    eggs, lab animals or cell cultures)

    GRAM (-) RODS

  • GRAM-NEGATIVE RODS

    Gram-negative enteric eubacteria causing

    diarrheal diseases other than Enterobacteriaciae

    Vibrio (marine & surface water)

    Campylobacter

    Helicobacter

    Aeromona (fresh water & cold-blooded animals)

    Plesiomona (cold & warm blooded animal)

    GRAM (-) RODS

  • EXAMPLES OF DISEASES PERPETUATED BY CONTAMINATED WATER

    BACTERIA VIRUSESHELMINTHS &

    PROTOZOA

    Escherichia coli Norovirus Dracunculi

    Salmonella sp. Rotavirus Schistosoma

    Shigella sp. Hepatitis A Cryptosporidium parvum

    Yersinia enterolitica Adenovirus Giardia lamblia

    Campylobacter sp. Astrovirus Leishmania

    Vibrio sp. Calcivirus Trypanosoma sp.

    Leptospira sp. Poliovirus Entamoeba histolytica

    Brucella sp. Polyomavirus Taenia solium

    Legionella Coronavirus Cyclospora

    Pleisomonasshigelloides

    Hemorrhagic fever (Flavirus Yellow, Dengue, Lassa, Ebola, Marburg)

    Microsporidia

    Aeromonas sp. Plasmodium sp

    Ascaris sp.

  • VIBRIO

  • VIBRIOS

    MORPHOLOGY & IDENTIFICATION

    one of the most common organisms in

    surface waters of the world.

    they occur in both marine and freshwater

    habitats and in associations with aquatic

    animals (plankton and algae)

    they survive in water for 3 weeks

    GRAM (-) RODS

  • VIBRIOS

    MORPHOLOGY & IDENTIFICATION

    gram-negative straight or curved or comma-shaped rods

    motile by means of a single polar flagellum

    non-spore former

    facultatively anaerobic (may or may not require oxygen for growth)

    capable of both respiratory & fermentative metabolism (ferments sucrose and mannose but not arabinose)

    alkaliphilic, characteristically grow in very high pH (8.5-

    9.5) & rapidly killed by acid

    halophilic, requiring the presence of NaCl to grow (except for V. cholerae) (unlike aeromonas)

    GRAM (-) RODS

  • VIBRIOS

    MORPHOLOGY & IDENTIFICATION

    Catalase-positive

    Oxidase-positive

    which differentiates them from Enterobacteriaciae on

    blood agar (a positive oxidase test is a key step in the preliminary identification of Vibrios)

    Susceptible to 2,4-diamino-6,7-diisopropylteridine

    phosphate (O/129)

    which differentiates them from aeromonas (aeromonasare resistant to O/129)

    GRAM (-) RODS

  • VIBRIOS

    MORPHOLOGY & IDENTIFICATION

    Transport medium: Cary-Blair semi-solid agar

    Enrichment medium: Alkaline peptone broth

    Selective/differential culture medium: TCBS

    (Thiosulfate Citrate Bile salts Sucrose) agar

    GRAM (-) RODS

  • VIBRIOS

    MEDICALY IMPORTANT SPECIES OF VIBRIO

    1. Vibrio cholera

    is noninvasive, affecting the small intestine through

    secretion of an enterotoxin

    2. Vibrio parahemolyticus

    is an invasive organism affecting primarily the colon

    3. Vibrio vulnificus

    is an emerging human pathogen

    causes wound infections, gastroenteritis, or a syndrome

    known as "primary septicemia

    GRAM (-) RODS

  • VIBRIOS

    MEDICALLY IMPORTANT VIBRIOS

    ORGANISM HUMAN DISEASE

    V Cholerae serogroupsO1 & O139

    Classic cholera (epidemic and pandemic)

    V cholerae serogroupsnon-O1/non-O139

    Cholera-like Mild diarrheaExtraintestinal infection

    V parahaemolyticus GastroenteritisExtraintenstinal infection

    V mimicus, V vulnificus, V hollisae, V fluvialis, V damsela, V anginolyticus, V metschnikovii

    Ear woundSoft tissue & other extraintestinal infections

    GRAM (-) RODS

  • 1. Vibrio cholerae

  • causative agent of Cholera or Asiatic cholera or

    Epidemic cholera

    is a rapidly dehydrating diarrheal disease that can lead to death, if appropriate tx is not provided immediately.

    human are the only known hosts

    transmission to humans is by ingestion of

    contaminated water or food (undercooked shellfish)

    thru fecal-oral route or oral-oral route

    natural reservoir of the organism is not known

    GRAM (-) RODS

    1. Vibrio cholerae

  • EPIDEMIOLOGY

    originated near Ganges Delta from India to

    Bangladesh

    responsible for seven global pandemics over the

    past two centuries

    the 7th pandemic is the most extensive and is caused by V. cholerae O1 El Tor.

    Endemic in India & SEA, and pandemic in Africa

    where sanitation is poor (very rare in industrialized countries)

    has an annual global burden of >1M people

    GRAM (-) RODS

    1. Vibrio cholerae

  • EPIDEMIOLOGY

    long-term carriage does not occur

    Risk factors in developing severe disease:

    blood group O

    decreased gastric acidity

    malnutrition

    immunocompromised state

    absence of local intestinal immunity

    GRAM (-) RODS

    1. Vibrio cholerae

  • VIBRIO CHOLERAEgram-negative, comma/curved/straight bacilli with a single flagellum at one pole

  • GENOMIC STRUCTURE

    The genome is approximately 4.0 Mb.

    The genome unusual in having two circular chromosomes (rather than one) with distinct origins of replication, the oriC1 and oriC2.

    Chromosome 1 (Large choromosome) CTX is an integrated filamentous bacteriophage that carries the genes for

    cholera toxin.

    VPI is a pathogenicity island carries genes for factors required for intestinal

    colonization.

    Chromosome 2 (small chromosome) Integron island is a structure that enables the sequential acquisition of

    novel genes by facilitating the insertion of newly acquired DNA fragments downstream of a strong transcriptional prompter. Although this integronisland has not yet been shown to be required for virulence in V. cholerae

    GRAM (-) RODS

    1. Vibrio cholerae

  • (B) Map of the CTX locus. The genes encoding the two subunits of cholera toxin are ctxAand ctxB. Other genes in the core region (ace and zot) are also involved in virulence. The two repeated flanking sequences RS2 and RS1 are involved in the chromosomal insertion of the bacteriophage genome

    (A) The two chromosomes of Vibriocholerae

  • ANTIGENIC STRUCTURE

    1. H or flagellar antigen

    - heat-labile, single, polar flagellum responsible for

    motility

    2. O or somatic lipopolysaccharide antigen on the

    cell wall

    - confers serologic specificity/used for specie identification

    GRAM (-) RODS

    1. Vibrio cholerae

  • CLASSIFICATION: SEROGROUPS AND BIOTYPES

    sub-classified into 200 serogroups based on the somatic O antigen

    only two strains have been implicated in the cholera syndrome/epidemics (medically important somatic O antigens are):

    1. O1 antigen

    2. O139 antigen

    O75 and O141 antigen are pathogenic and can

    cause small outbreaks

    GRAM (-) RODS

    1. Vibrio cholerae

  • ANTIGENIC

    DETERMI-

    NANTS

    RIBOTYPE

    BIOTYPE

    SEROTYPE

    GRAM (-) RODS

    TOXIGENIC VIBRIO CHOLERAE

    O1

    CLASSICAL

    Ogawa

    A, B

    Inaba

    A, C

    Hikojima

    A, B, C

    EL TOR

    Ogawa

    A, B

    Inaba

    A, C

    Hikojima

    A, B, C

    O139

    1. Vibrio cholerae

  • V CHOLERAE O1 ANTIGEN

    Genome is divided between a 2.4Mb large chromosome and a 1.6 Mb small chromosome.

    Two biotypes: (based on biochemical test such as phenotyping)

    1. CLASSIC

    2. EL TOR distinguished from classic biotypes by the production

    of hemolysin (which gives a positive Voges-Proskauer test)

    causes milder disease than the classic biotype but is

    able to survive in the body longer than classic biotype

    resistant to polymyxin B

    GRAM (-) RODS

    1. Vibrio cholerae

  • V CHOLERAE O139 ANTIGEN

    genome is divided between a 2.96 Mb large chromosome

    and a 1.07 Mb small chromosome

    also known as Bengal, the 139th and latest serogroup of V cholerae to be identified

    very similar to V cholerae O1 El Tor biotype

    does not possess the characteristic lipopolysaccharide

    O1 somatic antigen

    makes a polysaccharide capsule like other non-O1 V

    cholerae strain (V cholerae O1 does not make a capsule)

    GRAM (-) RODS

    1. Vibrio cholerae

  • V CHOLERAE O139 ANTIGEN

    This serovar is identified by:

    1. absence of agglutination in O1 group specific

    antiserum;

    2. presence of agglutination in O139 group

    specific antiserum;

    3. presence of a capsule

    GRAM (-) RODS

    1. Vibrio cholerae

  • VIRULENCE FACTORS

    Toxins

    o Exotoxin/Enterotoxin known as Cholera Toxin or Choleragen

    o HA Protease

    o RTX Toxin

    o ACE and Zot

    Adhesins

    o Accessory Colonization Factors (ACF)o OmpU & other Omp Proteins (outer membrane proteins)o Mannose-fucose-resistant cell hemagglutinin & Mannose

    sensitive hemagglutinino Toxin Co-regulated Pilus (TCP)

    Integrons

    GRAM (-) RODS

    1. Vibrio cholerae

  • GRAM (-) RODS

    1. Vibrio cholerae

    VIRULENCE FACTOR of V cholerae BIOLOGIC EFFECT

    Cholera toxin or Choleragen Hypersecretion of electrolytes and water

    Co-regulated pilus Adherence to mucosal cells

    Accessory colonization Adhesin factor

    Hemagglutination-protease

    (mucinase)

    Induces intestinal inflammation and degradation of tight

    junctions

    Neuraminidase Increased toxin receptors

    Non-cholerae Vibrios VIRULENCE FACTORS

    V. parahaeolyticus Thermostable direct hemolysin

    V. vulnificus Serum resistance, antiphagocytic polysaccharides, cytolysins,

    collagenase, protease, siderophores

    V. alginolyticus Collagenase

    V. hollisae Heat-stable and heat-labile enterotoxin, hemolysin

    V. damsela cytolysin

  • Cholera Enterotoxin or Choleragen(A2-5B)

    main cause of the voluminous watery diarrhea that is

    characteristic of cholera

    an A-B type exotoxin

    composed of protein, highly antigenic, heat-labile, and

    highly potent

    encoded by the bacteriophage, ctxAB genes

    - ctxAB genes convert bacterial host from a nonpathogenic form

    to a pathogenic form by providing the bacterium with virulence

    genes, in a process called lysogenic phage conversion

    structurally & functionally similar to ETEC LT

    GRAM (-) RODS

    1. Vibrio cholerae

  • 1. B-subunit binds to GM1 ganglioside

    receptors in thesmall intestinal

    epithelial cells or enterocytes

    2. After binding, A subunit is released

    into the cells, where it stimulates a

    cascade of events: Reduction of

    disulfide bond in A-subunit activates

    A1 fragment that ADP-ribosylates

    guanosine triphosphate (GTP)-binding

    protein (Gs) by transferring ADP-ribose

    from nicotinamide adenine

    dinucleotide (NAD)

    3. ADP-ribosylated GTP-binding protein

    activates adenyl cyclase leading to an

    increased cyclic AMP (cAMP) level

    Increase in cAMP leads to increase

    chloride secretion by the crypt cells,

    which in turn leads to inhibition of

    absorption of sodium and chloride by

    the microvilli (hypersecretion of fluids

    and electrolytes)

  • PATHOGENESIS & PATHOLOGY

    1. ENTRY: fecal-oral or oral-oral route

    - Incubation period: 1-3 days (range: several hours to 5 days)

    - Water (infectious dose = 109CFU); Food (infectious dose = 103CFU)

    - can be transmitted from person-to-person

    2. COLONIZATION: proximal small intestine

    - Vibrios are sensitive to acid, and most die in the stomach but in order to survive in the

    GI tract, they undergo changes such as:

    - increased expression of genes required for nutrient acquisition

    - downregulation of chemotactic response

    - expression of motility

    - adhere to and colonize in the alkaline environment of the proximal small bowel, where

    they secrete the potent cholera enterotoxin causing massive secretion of electrolytes

    and water into the intestinal lumen (diarrhea occurs as much as 20-30 L/day )

    GRAM (-) RODS

    1. Vibrio cholerae

  • PATHOGENESIS & PATHOLOGY

    3. DISEASE:

    - rapid and massive loss of electrolyte rich isotonic fluid in the small intestine that

    exceeds the absorptive capacity of the colon resulting to rapid and profound

    dehydration and depletion of electrolytes (sodium, chloride, bicarbonate and

    potassium) leading to metabolic acidosis, hypokalemia, anuria, hypovolemic shock, and

    circulatory collapse

    - not an invasive infection (do not reach the bloodstream)

    4. EXIT: anus

    GRAM (-) RODS

    1. Vibrio cholerae

  • CLINICAL FINDINGS

    most patients are asymptomatic

    some may have mild to moderate diarrhea, associated

    with abdominal pain and muscle cramping for 3-7 days

    rice water - characteristic stool - colorless with fishy odor, small flecks of mucus, and contains

    epithelial cells & large nos of vibrios, and high concentration of

    sodium, potassium, chloride and bicarbonate

  • CLINICAL FINDINGS

    Cholera gravis

    most severe form of the disease

    sudden onset of massive, profuse watery diarrhea (20-30 L/day

    or 500-1000ml/hr) with or without abdominal cramps, nausea &

    vomiting

    characteristic rice water stool severe dehydration (lethargic appearance, sunken eyes/fontanels,

    absence of tears, dry oral mucosa, poor skin turgor/skin pinch goes back very slowly, unable to drink or feed, poor capillary refill)

    Washerwomans hands (shriveled hands and feet) Kussmaul breathing (rapid, deep breathing due to metabolic acidosis),

    decreased urine output

    thready pulse and tachycardia

    hypotension and hypovolemicshock

    GRAM (-) RODS

    1. Vibrio cholerae

  • Adult cholera gravis patient with washer womans hand sign

    Severely dehydrated pediatric patient with Cholera gravis

  • Rice-water stool of Vibriocholerae

    Cholera cot:

    - Made of folding canvas with 9 hole just above

    the middle

    - Bucket under the opening to collect stool

    - Dip-stick calibrated to measure stool volume

    directly from the pail

  • COMPLICATIONS:

    delayed /inadequate rehydration may lead to:

    renal failure due to prolonged hypotension

    hypokalemia may lead to nephropathy and focal myocardial

    necrosis

    hypoglycemia may lead to seizures or coma

    may progress from the first liquid stool to shock in 4-12 hours,

    with death following in 18 hours to several days.

    in its extreme manifestation with no treatment, it is one

    of the most rapidly fatal illnesses known with 50-60%

    mortality rates (hypotention within an hour of the onset of symptoms and death within 2-3 hours)

    GRAM (-) RODS

    1. Vibrio cholerae

  • HOST DEFENSES

    Nonspecific: Gastric acid, mucus secretion, and

    intestinal motility

    Specific: involves primarily secretory IgA, as well

    as IgG antibodies against vibrios, somatic antigen,

    outer membrane protein, and/or the enterotoxin

    and other products.

    Breastfeeding in endemic areas is important in

    protecting infants from disease

    GRAM (-) RODS

    1. Vibrio cholerae

  • DIAGNOSIS

    1. Microscopy: (using stool specimen)

    Gram-negative, comma-shaped, curved bacilli,

    2-4 um long (on prolonged isolation, may become straight rods that resemble the gram-negative enteric bacteria) not distinctive

    Dark-field microscopy for rapid diagnosis, a

    wet mount of liquid stool may show the

    characteristic darting motility of vibrios(which is stopped by specific antisomatic antibody)

    GRAM (-) RODS

    1. Vibrio cholerae

  • DIAGNOSIS

    2. Culture: (gold standard for diagnosis)

    specimen/s: stool, vomitous or rectal swabs

    Selective medium TCBS (Thiosulfate citrate bile salt sucrose

    agar) produces yellow colonies that are convex, smooth, round,

    and opaque & granular in transmitted light

    Transport medium Cary-Blair agar if cannot be processed

    immediately

    enrichment medium in alkaline peptone broth (up to pH 9)

    blood agar with pH9 (oxidase-positive)

    Definitive diagnosis not required for initiation of treatment, laboratory confirmation is necessary for epidemiologic surveillance

    GRAM (-) RODS

    1. Vibrio cholerae

  • Yellow colonies on TCBS agar

    Oxidase-positive on blood agar

  • DIAGNOSIS

    3. Direct antigen detection dipstick tests

    extremely useful since results are available within minutes

    4. Slide agglutination tests using anti-O group 1 and

    139 antiserum

    5. Biochemical tests

    6. Serotyping/serogrouping

    four-fold increase in antibody titer between acute and convalescent serum

    7. PCR and DNA rpobes

    GRAM (-) RODS

    1. Vibrio cholerae

  • DIAGNOSIS

    6. Others:

    fecalysis may only show few leukocytes and

    erythocytes because of absence of inflammation

    elevated urine specific gravity (concentrated urine)

    hemoconcentration

    hypoglycemia

    metabolic acidosis

    GRAM (-) RODS

    1. Vibrio cholerae

  • TREATMENT

    1. Water and electrolyte replacement is the first priority in

    the treatment of cholera. Rehydration is accomplished in 2

    phases: rehydration and maintenance.

    Rehydration phase is to restore normal hydration status, which should take no more than

    4 hours. Set the rate of intravenous infusion in severely dehydrated patients at 50-100

    mL/kg/hr. Lactated Ringer solution is the solution of choice, preferred over isotonic

    sodium chloride solution because saline does not correct metabolic acidosis. If normal

    saline is used, ORS should be given simultaneously to supplement base and potassium.

    Maintenance phase is to maintain normal hydration status by replacing ongoing losses.

    The oral route is preferred, and the use of oral rehydration solution (ORS) at a rate of

    500-1000 mL/hr is recommended.

    GRAM (-) RODS

    1. Vibrio cholerae

  • TREATMENT

    2. Antibiotics:

    reduce toxin production,shorten duration of illness, decrease fecal excretion of vibrio,

    decrease volume of diarrhea, and reduce fluid requirement during rehydration

    Antibiotic of choice:

    Doxycycline (for adults and older children) 300 mg OD

    Tetracycline 12.5 mg/kg/dose (up to 500 mg/dose) QID x 3 days

    Trimethoprim-sulfamethoxazole/Cotrimoxazole (for children)

    Furazolidone (for pregnant women)

    Alternative:

    Erythromycin (for adults and children) 12.5 mg/kg/dose (up to 250 mg/dose) QID x 3 days

    GRAM (-) RODS

    1. Vibrio cholerae

  • TREATMENT

    3. Zinc supplementation

    for re-epithelialization of intestinal villi

    shown to lessen stool output

    antibiotics and zinc should be given as soon as vomiting stops.

    any medication or condition that decreased the stomach acidity makes a person more susceptible to infection

    Antimotility, antiemetics, adsorbents and analgesics are not recommended

    GRAM (-) RODS

    1. Vibrio cholerae

  • GRAM (-) RODS

    1. Vibrio cholerae

  • EPIDEMIC CONTROL MEASURES

    information dissemination, improvement of sanitation, adequate

    supply of water, disinfection of excreta, isolation of patients,

    contacts follow up

    Good food hygiene

    - thoroughly cooking food

    - eating food while its hot

    - preventing cooked foods from contacting raw foods (including water or ice)

    - avoiding raw fruits or vegetables

    - washing hands after defecation & before cooking

    LIMITED ROLE: (not effective as an epidemic control measure)

    - Chemoprophylaxis with antimicrobial drugs

    - Repeated vaccination with either LPS extracted from vibrio or dense vibrio suspension

    (valid only for 6 months)

    GRAM (-) RODS

    1. Vibrio cholerae

  • 2. Vibrio parahaemolyticus

    3. Vibrio vulnificus

  • GRAM (-) RODS

    2. Vibrio parahaemolyticus

    Physiology and

    Structure

    - Facultative anaerobe, curved gram-negative bacilli

    - Fermenter

    - Simple nutirtional requirements but requires salt for growth

    Virulence - Hemolysin and Adhesin (does not produce enterotoxin)

    Epidemiology - Organism found in estuarine and marine environments worldwide

    - Associated with consumption of contaminated shell-fish

    - Major pathogen in countries where raw fish is eaten

    Disease - Incubation period of 12-24 hr

    - Diarrhea ranging from mild disease to a cholera-like illness

    - Typical presentation is an explosive, watery to bloody diarrhea with

    abdominal cramps and fever

    - Less commonly associated with wound infections and bacteremia

    Diagnosis - Produces green colonies on TCBS agar

    Treatment,

    Prevention and

    Control

    - Self-limiting

    - Rehydration and antibiotics can shorten symptoms and fluid loss

    - Disease prevented by proper cooking of shellfish

    - No vaccine available

  • GRAM (-) RODS

    3. Vibrio vulnificus

    Physiology and

    Structure

    - Facultative anaerobe, curved gram-negative bacilli; fermenter

    - Simple nutritional requirements but requires salt for growth

    Virulence - Antiphagocytic capsule

    - Production of hydrolytic enzymes (cytolysin, collagenase, proteases)

    - Resistant to complement and antibody-mediated serum killing

    Epidemiology - Free-living estuarine bacterium found in oyster during warm months

    - Infection associated with exposure to contaminated salt water or

    ingestion of improperly cooked shellfish

    Disease - Wound infection that can progress rapidly to formation of bullae and

    tissue necrosis

    - Bacteremia/septicemia and gastroenteritis following ingestion of

    contaminated shellfish with fever and watery to bloody diarrhea

    - Life-threatening with high mortality rate (50%)

    Diagnosis - produces blue-green colonies on TCBS agar; sucrose-negative

    Treatment,

    Prevention and

    Control

    - Prompt antibiotic treatment with Tetracycline or Aminoglycosides (DOC)

    - Rehydration

    - Aggressive wound treatment

    - No vaccine available

  • VIBRIO VULNIFICUS

    edema; ecchymoses; and hemorrhagic, serous bullae on

    the lower legsNecrotizing fascitis

  • CAMPYLOBACTER

  • CAMPYLOBACTER

    among the most common widespread causes

    of infection in the world in human, domestic

    animals, and wild bird

    causes both diarrheal and systemic diseases

    ranging from mild to severe infection

    recently, Campylobacter infections have

    been identified as the most common

    antecedent to an acute neurological disease,

    the Guillain-Barr syndrome.

    GRAM (-) RODS

  • CAMPYLOBACTER

    MEDICALY IMPORTANT SPECIES OF CAMPYLOBACTER

    1. Campylobacter jejuni

    2. Campylobacter coli

    both C. jejuni and C. coli are usually associated with gastroenteritis

    3. Campylobacter fetus

    an opportunistic pathogen that causes extraintestinal, bacteremia, and systemic infections in immunocompromisedpatients

    GRAM (-) RODS

  • EPIDEMIOLOGY

    endemic worldwide and hyperendemic in

    developing countries

    infants and young adults are most often

    infected

    incidence peaks in the summer

    outbreaks are associated with contaminated

    animal products or water

    GRAM (-) RODS

    CAMPYLOBACTER

  • MORPHOLOGY & IDENTIFICATION

    gram-negative, thin (0.2-0.4 um wide) short rods

    (1.5-3.5 um long), that usually have tapered ends

    and have various morphology including

    comma, curved, S, or gull-wing shapes

    they are motile with single flagellum

    microaerophilic, thermophilic

    unable to oxidize or ferment carbohydrates

    oxidase- and catalase-positive

    GRAM (-) RODS

    CAMPYLOBACTER

  • CAMPYLOBACTERgram-negative, comma-/curved-/S-/gull-wing-shaped bacilli with single flagellum

  • PATHOGENESIS & PATHOLOGY

    amount of organism to cause infection: 104

    INCUBATION PERIOD: 1-7 days

    TRANSMISSION:

    oral ingestion of contaminated poultry, raw milk, water

    direct contact with infected farm and pet animals

    airborne transmission (common among farm workers)

    person-to-person spread occurs occasionally

    GRAM (-) RODS

    CAMPYLOBACTER

  • PATHOGENESIS & PATHOLOGY

    GRAM (-) RODS

    CAMPYLOBACTER

    Ingestion of contaminated food by

    susceptible host

    Passage through the stomach into

    the intestines

    Colonization and cell invasion of the SI and LI

    epithelial cells

    Toxin production in the intestines

    Massive inflammatory response and increased

    cytokines

    Diarrheal disease

    and blood in stool

  • PATHOGENESIS & PATHOLOGY

    COLONIZATION, VIRULENCE and CELL INVASION of SI and LI epithelial

    cells is facilitated by:

    1. Polysaccharide capsule

    2. Lipooligosaccharide

    display molecular mimicry of neuronal ganglioside of C. jejuni, which is

    linked to Guillaine-Barre and Miller-Fischer syndrome

    3. Flagellin/Flagellum

    acts as secretion apparatus for antigens invasion

    for motility bacteria can translocate across intestinal epithelial cells via:

    a) Transcellular route (eg. C. fetus)

    b) Paracellular route (eg C. concisus) by breaking down tight junctions

    4. T4SS (Type 4 secretion system)

    secretes effector proteins (eg. C. fetus, C. rectus)

    GRAM (-) RODS

    CAMPYLOBACTER

  • PATHOGENESIS & PATHOLOGY

    5. Surface glycans

    a) O-linked glycosylation

    modifies the flagellin needed for flagellar assembly

    b) N-linked glycosylation

    modifies periplasmic and outer-membrane proteins (bacterial surface)

    6. S-layer protein (Surface layer)

    high molecular weight capsule-like structure found on the surface of C. fetus

    and C. rectus that mediates high-level resistance to serum-mediated killing

    and phagocytosis by inhibiting stable complement deposition onto bacterial

    cell surface during the systemic phase of infection

    responsible for bacteremia.

    GRAM (-) RODS

    CAMPYLOBACTER

  • PATHOGENESIS & PATHOLOGY

    TOXIN PRODUCTION:

    1. Interleukin-8

    causes recruitement of dendritic cells, macrophages and neutophils

    2. Tripartite cytolethal distending toxin

    mediated by CdtA and CdtC followed by CdtB

    initiates cell cycle arrest and DNA damage

    produce by C. fetus, C. coli, C. lari, C. upsaliensis and C. hyointestinalis

    3. Hemolysin

    lyse RBCs

    GRAM (-) RODS

    CAMPYLOBACTER

  • PATHOGENESIS & PATHOLOGY

    GRAM (-) RODS

    CAMPYLOBACTER

  • CAMPYLOBACTERGRAM (-) RODS

    CAMPYLOBACTER SPECIES ASSOCIATED WITH HUMAN DISEASE

    SPECIES DISEASES IN HUMANS COMMON SOURCES

    C. jejuni Gastroenteritis, bacteremia, Guillain-Barre Syndrome Poultry, raw milk, cats, dogs, cattle, swine, monkeys, water

    C. coli Gastroenteritis, bacteremia Poultry, raw milk, cats, dogs, cattle, swine, monkeys, water, oyster

    C. fetusBacteremia, meningitis, endocarditis, mycotic aneurysm,

    diarrheaSheep, cattle, birds

    C. hyointestinalis Diarrhea, bacteremia, proctitis Swine, cattle, deer, hamster, raw milk, oyster

    C. lari Diarrhea, colitis, appendicitis, bacteremia, UTI Seagulls, water, poultry, cattle, dogs, cats, monkeys, oyster, mussels

    C. upsaliensisDiarrhea, bacteremia, abscesses, enteritis, colitis,

    hemolyticuremiaCats, other domestic pets

    C. concisus Diarrhea, gastritis, enteritis, periodontitis Human oral cavity

    C. sputorum Diarrhea, bedsores, abscesses, periodontitis Human oral cavity, cattle, swine

    C. rectus Periodontitis

    C. mucosalis Enteritis swine

    C. doylei Diarrhea, colitis, appendicitis, bacteremia, UTI Swine

    C. curvus Gingivitis, alevolar abscessPoultry, raw milk, cats, dogs, cattle, swine, monkeys, water, human

    oral cavity

    C. gracilis Head and neck abscess, abdominal abscess, empyema

    C. cryaerophila Diarrhea swine

  • HOST DEFENSES

    Nonspecific: Gastric acid, mucus secretion, and

    intestinal motility

    Specific: intestinal immunoglobulin (IgA) and

    systemic antibodies

    Persons deficient in humoral immunity develop

    severe and prolonged illnesses.

    GRAM (-) RODS

    CAMPYLOBACTER

  • CLINICAL MANIFESTATIONS

    1. Acute gastroenteritis

    90-95% is caused by C. jejuni and C.coli

    prodrome of fever, headache, abdominal pain and myalgia, and within

    a day develop loose, watery stool, may be bloody in severe cases.

    mild disease lasts 1-2 days (resembles viral gastroenteritis)

    Severe/persistent disease can mimic Shigella dysentery and acute

    inflammatory bowel disease (IBD)

    most patients recover in less than a week (20-30% remain ill for 2

    weeks)

    fatalities are rare

    GRAM (-) RODS

    CAMPYLOBACTER

  • CLINICAL MANIFESTATIONS

    2. Bacteremia/Septicemia

    From C. jejuni/coli:

    common among malnourished children, patients with chronic illnesses

    or immunodeficiency, and at extremes of ages

    usually asymptomatic

    if symptomatic, may cause enteric fever (headache, malaise, abdominal

    pain, relapsing fever, night sweat, chills), weight loss, lethargy,

    confusion, and even cough

    From C. fetus:

    occurs in adults with or without identifiable focal infections usually in

    patients with malignancy and DM

    GRAM (-) RODS

    CAMPYLOBACTER

  • CLINICAL MANIFESTATIONS

    3. Focal Extraintestinal Infections

    commonly caused by C. fetus among neonates and

    immunocompromised patients; and rarely caused by C. jejuni/coli

    usually associated with vascular endothelium causing endocarditis,

    pericarditis, thrombophlebitis, and mycotic aneurysms

    can also cause meningitis, septic arthritis, osteomyelitis, UTI, lung

    abscess and cholangitis

    GRAM (-) RODS

    CAMPYLOBACTER

  • CLINICAL MANIFESTATIONS

    4. Perinatal infections

    commonly caused by C. fetus and rarely by C. jejuni/coli

    may result to abortion, stillbirth, premature delivery or neonatal

    infection with bloody diarrhea, sepsis and meningitis

    GRAM (-) RODS

    CAMPYLOBACTER

  • COMPLICATIONS

    1. Guillain-Barr syndrome (Acute Idiopathic Polyneuritis)

    because of molecular mimicry between nerve tissue and Campylobacter jejuni

    surface antigen

    2. Miller Fischer syndrome (ophthalmoplegia, arelexia, ataxia)

    3. Reiter syndrome (arthritis, urethritis, bilateral conjunctivitis)

    4. Irritable bowel syndrome

    5. Reactive Arthritis

    seen in adolescents and adults who are positive for HLA-B27

    appears 5-40 days after onset of diarrhea

    involves large joints, typically migratory and resolves without sequelae

    6. IgA nephropathy and immune complex glomerulonephritis

    7. Hemolytic anemia

    GRAM (-) RODS

    CAMPYLOBACTER

  • DIAGNOSIS

    1. Culture: (using stool specimen)

    Selective media: Skirrows, Butzlers, Campy-BAP

    Incubate at reduced oxygen (5% O2), increased carbon

    dioxide (10% CO2), and 42oC (growth of other bacteria present in the feces are inhibited at 42oC temp, thus simplifying ID of C jejuni)

    colonies are colorless or gray. May either be

    watery and spreading or round and convex

    contains vancomycin, polymixin B and

    Trimethoprin (these inhibit growth of other bacteria)

    GRAM (-) RODS

    CAMPYLOBACTER

  • DIAGNOSIS

    2. Microscopy: (using stool specimen)

    gram-negative rods with thin, comma/curved,

    S, or gull-wing shapes (insensitive)

    dark-field microscopy may show typical

    darting motility (rapid, presumptive test)

    3. Antigen detection by ELISA

    4. PCR and DNA probes

    GRAM (-) RODS

    CAMPYLOBACTER

  • DIAGNOSIS

    5. Others:

    fecal leukocytes in 75% of cases

    fecal blood in 50% of cases

    GRAM (-) RODS

    CAMPYLOBACTER

  • TREATMENT

    Mild gastroenteritis

    self-limiting for a period of 5-8 days

    managed by fluid and electrolyte replacement

    Severe gastroenteritis and septicemia

    Erythromycin (drug of choice)

    Tetracyclines

    fluoroquinolones

    GRAM (-) RODS

    CAMPYLOBACTER

  • CONTROL

    information dissemination

    public health control measures

    GRAM (-) RODS

    CAMPYLOBACTER

  • HELICOBACTER

  • Helicobacter pylori

    found deep in the mucous layer of gastric mucosa.

    most commonly affects pylorus and antrum along

    lesser curvature

    overlies gastric type epithelial cells but not

    intestinal epithelial cells

    classified as type I carcinogen by WHO

    GRAM (-) RODS

  • Helicobacter pylori

    associated with:

    antral gastritis and a/hypochlorhydria

    duodenal/peptic ulcer disease (90%)

    gastric ulcers (50-80%)

    gastric adenocarcinoma

    gastric mucosa-associated lymphoid tissue (MALT) B-

    cell lymphomas

    GRAM (-) RODS

  • Helicobacter pylori

    worldwide distribution; about 1/3 of the world's

    population is infected

    prevalence of infection increases with age

    reservoir is humans but the exact modes of

    transmission are not known

    person-to-person transmission is common

    H pylori has now been isolated from feces and

    dental plaque

    acute epidemics of gastritis suggest a common

    source of H pylori

    GRAM (-) RODS

  • MORPHOLOGY & IDENTIFICATION

    gram-negative, spiral-shaped bacilli

    motile with multiple flagella at one pole

    grows in 3-6 days at 370c in a micro-

    aerophilic environment

    has very high urease production

    oxidase and catalase positive

    grows optimally at pH 6-7

    Helicobacter pyloriGRAM (-) RODS

  • HELICOBACTER PYLORIgram-negative, spiral-shaped bacilli with multiple flagella at one pole

  • Electron photomicrograph of

    Helicobacter pylori

    Electron photomicrograph of H. pylori adherence to gastric

    mucosa epithelium

  • PATHOGENESIS & PATHOLOGY

    under normal condition, gastric mucus is relatively impermeable

    to acid and has a strong buffering capacity. pH is low (1-2) on the

    mucus side of the lumen while pH is physiologic (7.4) on the

    epithelial side of the lumen.

    H pylori produces a protease that modifies the gastric mucus and

    further increases the ability of acid to diffuse through the mucus

    H pylori produces potent urease activity, which yields production

    of ammonia and further buffering of acids causing direct damage

    to the epithelial cells

    Toxins and LPS may damage the cells also

    Helicobacter pyloriGRAM (-) RODS

  • Helicobacter pyloriGRAM (-) RODS

  • CLINICAL FINDINGS

    Clinical manifestations

    fever

    crampy abdominal pain

    nausea

    vomiting of acid-free gastric juice (hypo/achlorhydria)

    putrid breath

    acute symptoms may last for 1-2 weeks. But

    once colonized, may persists for years or

    even a lifetime

    Helicobacter pyloriGRAM (-) RODS

  • DIAGNOSIS

    1. Gastric biopsy (gastroscopy) for

    histologic examination

    confirmatory test for H. Pylori infection

    (most sensitive & specific)

    Helicobacter pyloriGRAM (-) RODS

  • H. pyloripositive patient (left) and an H. pylorinegative patient (right):-H pylori positivity is associated with risk of gastric cancer, whereas H. pylori negativity is associated with risk of esophageal adenocarcinoma or EAC.-The presence of H. pylori (left) is indicated by the dark curved bacilli in the mucus layer adjacent to the epithelial cell surfaces. - The H. pylori (+) biopsy shows deeper staining of the epithelial cells, indicating tissue reactivity, and the lamina propria shows increased mononuclear cell numbers (compared with the H. pylori (-)biopsy)

  • DIAGNOSIS

    2. Culture: (using stool specimen)

    Skirrows & Chocolate agar (Colonies are translucent 1-2 mm)

    incubation in microaerophilic conditions

    growth is slow

    relatively insensitive unless multiple biopsies are

    cultured

    Helicobacter pyloriGRAM (-) RODS

  • DIAGNOSIS

    3. Microscopy: (specimen from gastric biopsy)

    spiral-shaped, gram-negative rods with multiple

    flagella in one pole

    Giemsa or special silver stains

    Dark-field microscopy may show motility

    Helicobacter pyloriGRAM (-) RODS

  • CULTURE. Heavy growth of H. pylori from an antral biopsy specimen from a patient with duodenal ulcer. (larger white colonies are commensal flora of the mouth)

    GRAM STAIN. spiral-shaped, gram-negative rods with multiple flagella in one pole

  • DIAGNOSIS

    4. Serology:

    Blood for serum antibody determination

    H. pylori antigen test (sensitive and specific; performed with stool specimens)

    useful for demonstrating exposure to H. Pylori

    Helicobacter pyloriGRAM (-) RODS

  • DIAGNOSIS

    5. Urea breath test

    relatively sensitive and highly specific

    non-radioactive 13C or radioactive 14C-labeled urea

    capsule is ingested by patient.

    Principle: H. pylori produces an enzyme urease which converts urea to ammonia and carbon dioxide. When H. pylori is present in the stomach, the enzyme urease, produced by Helicobacter pylori, will convert 13C or 14C-labeled urea in the test drink into ammonia and carbon dioxide. The generated labeled CO2 from patients exhaled breath is measured using a heliprobe machine

    Helicobacter pyloriGRAM (-) RODS

  • Drink. 13C or 14C-labeled urea capsule

    Exhale.labeled CO2 into a chamber

    Measure.exhaled labeled CO2 from chamber using a heliprobemachine

    Interpret.51: positive

  • TREATMENT

    1. Triple antimicrobial therapy for 14 days (eradicates infection in 70-95% of patients)

    Bismuth subsalicylate or bismuth subcitrate

    Metronidazole

    Amoxicillin or Tetracycline or Clarythromycin

    2. Proton-pump inhibitors (directly inhibit H pylori, potent ureaseinhibitors, & enhances ulcer healing)

    Omeprazole

    option 1

    metronidazole

    bismuth (Pepto-bismol)

    Helicobacter pyloriGRAM (-) RODS

  • TREATMENToption 1 (BMT or BMA)

    Bismuth (Pepto-bismol)

    Metronidazole

    either Tetracycline or Amoxicillin

    option 2

    Metronidazole

    Clarithromycin

    Omeprazole

    80-95% PPI+ clarythro+amox

    90-99% PPI+bismuth+metro+tetra or amox

    Helicobacter pyloriGRAM (-) RODS

  • OTHERS

  • Aeromonas sps.

    gram-negative, facultative anaerobic rod

    oxidase-positive

    ubiquitous and free-living in fresh and

    brackish water

    TRANSMISSION:

    oral ingestion of contaminated water & food

    direct contact with contaminated water & food (medicinal leech therapy)

    GRAM (-) RODS

  • 14 species but the 3 most important species

    of primary clinical importance are:

    Aeromonas hydrophila

    Aeromonas caviae

    Aeromonas veronii biovar sobria

    GRAM (-) RODS

    Aeromonas sps.

  • CULTURE of Aeromonas hydrophilaon horse blood agar

    CULTURE of Aeromonas hydrophilaon TCBS agar

  • ELECTRON PHOTOMICROGRAPH. Aeromonas hydrophila

    GRAM STAIN. Aeromonas hydrophila

  • Clinical diseases:

    1. Gastroenteritis

    - most common clinical manifestation

    2. Wound infections (with or without bacteremia)

    3. Primary and secondary septicemia (in immunocompromised

    persons)

    4. Peritonitis, meningitis, and infections of the eye, joints, and

    bones (less well described illnesses)

    GRAM (-) RODS

    Aeromonas sps.

  • Treatment (Antimicrobial therapy is necessary in patients with chronic diarrheal disease or systemic infection)

    Ciprofloxacin

    Gentamicin

    Amikacin

    Trimethoprim-sulfamethoxazole

    GRAM (-) RODS

    Aeromonas sps.

  • Plesiomonas shigelloides

    gram-negative rod

    motile with multiple polar flagellum

    non-lactose fermenter

    oxidase-positive (some Plesiomonas strains share antigens with Shigella sonnei, and cross-reactions with Shigella antisera occur thus the name shigelloides. Plesiomonas can be distinguished from Shigella in diarrheal stools by an oxidase test. Shigella sps. are oxidase-negative)

    DNase-positive (aeromonas Dnase-negative)

    GRAM (-) RODS

  • ELECTRON PHOTOMICROGRAPH. Plesiomonas sp.

    GRAM STAIN. Plesiomonas sp.

  • Plesiomonas shigelloides

    primarily a freshwater aquatic organism

    generally found in fresh or estuarine (brackish)

    waters rather than marine environments

    most common in tropical and subtropical areas

    acquired from contaminated freshwater fish and

    animals resulting to diarrhea

    GRAM (-) RODS

  • Plesiomonas shigelloides

    Acquired by ingestion of or exposure to

    contaminated water or seafood or by exposure to

    amphibians or reptiles

    Self-limited gastroenteritis: secretory colitis or

    chronic forms

    Variety of uncommon extra-intestinal infections

    GRAM (-) RODS

  • RICKETSSIAE

  • RICKETTSIACEAE

    GENERA

    Rickettsia

    Orientia

    Coxiella

    Ehrlichia

    UNIQUE BACTERIA

  • RICKETTSIACEAE

    MORPHOLOGY & IDENTIFICATION

    small (0.3-0.5 x 0.8-2.0 um), gram-negative, pleomorphic,

    coccobacilli (lack flagella, non-motile)

    obligate intracellular (Energy Parasites) except for Coxiella

    divide by binary fission

    reside within the cytoplasm or within the nucleus of the

    cell that they invade

    they metabolize host-derived glutamate via aerobic

    respiration and the citric acid (TCA) cycle

    UNIQUE BACTERIA

  • RICKETTSIACEAE

    MORPHOLOGY & IDENTIFICATION

    reservoir are animals and arthropds (humans are accidentally infected with these organisms)

    all are transmitted by arthropod vectors(e.g., ticks, mites, lice or fleas) except Coxiella

    typically manifested by fever, rashes and vasculitis

    except for Coxiella

    UNIQUE BACTERIA

  • PATHOGENESIS

    MOT: inoculated into the dermis of the skin by a tick bite

    or through damaged skin from the feces of lice or fleas

    TARGET CELLS: spread through the bloodstream and infect

    the endothelial cells lining of small blood vessels of all

    major tissues and organs. - Destruction of endothelial cells results in leakage of blood and subsequent organ

    and tissue damage due to loss of blood into the tissue spaces

    VIRULENCE FACTORS

    Adhesins: OmpA (outer membrane protein A)

    UNIQUE BACTERIA

    RICKETTSIACEAE

  • 1. Adhere to endothelial cells lining the small blood vessels by parasite-induced phagocytosis2. Once in the host cell, the bacteria lyse the phagosome membrane with a phospholipase and escape into the host cell

    cytoplasm where they replicate. 3. The mode of exit from the host cell varies depending upon the species

    - R. prowazekii exits by cell lysis- R. rickettsii get extruded from the cell through local projections (filopodia). F actin in the host cell associates with R. rickettsii

    and the actin helps to "push" the bacteria through the filopdia- O. tsutsugamushi exits by budding through the cell membrane and remains enveloped in the host cell membrane as it infects

    other cells.

  • HOST DEFENSES

    Humoral immunity

    - antibody-opsonized Rickettsia are phagocytosed and killed by

    macrophages

    C-cell mediated immunity

    Delayed type hypersensitivity develops following

    rickettsial infections.

    UNIQUE BACTERIA

    RICKETTSIACEAE

  • THREE MAJOR GROUPS: (based on clinical characteristics of disease)

    UNIQUE BACTERIA

    SPOTTED FEVER GROUP TYPHUS GROUP Ehrlichiae

    -Rickettsia rickettsii

    -Rickettsia akari

    -Coxiella burnetii

    -Rickettsia prowazekii

    -Rickettsia typhi

    -Orientia (Rickettsia)

    tsutsugamushi

    - Ehrlichia chaffeensis

    -Ehrlichia phagocytophilia

    -Ehrlichia ewingii

    -R. aeschlimannii

    -R. africae

    -R. australis

    -R. conorii

    -R. felis

    -R. honei

    -R. helvitica

    -R. japonica

    -R. japonica

    -R. massilae

    -R.

    mongolotimonae

    -R. montanensis

    -R. parkeri

    -R. peacockii

    -R. rhipicephali

    -R. sibirica

    -R. slovaca

    -R. felis

    - R. bellii

    -R. canadensis

    RICKETTSIACEAE

  • RICKETTSIAL DISEASES:

    UNIQUE BACTERIA

    Disease Organism Vector Reservoir

    SPOTTED FEVER GROUP

    Rocky Mountain spotted fever R. rickettsii Tick Ticks, wild rodents

    Rickettsialpox R. akari Mite Mites, wild rodents

    Q fever C. burnetii Inhalation of contaminated dust

    TYPHUS GROUP

    Epidemic/Louse-borne typhus R. prowazekii LouseHumans, squirrel fleas,

    flying squirrels

    Endemic/Murine typhus R. typhi Flea Wild rodents

    Scrub typhus R. tsutsugamushi Mite Mites, wild rodents

    ERLICHIAE

    Human monocyte ehrlichiosis E. chaffeensis Tick Deer

    Human granulocyte ehrlichiosis E. phagocytophila Tick Mouse, other mammals

    E. ewingii Tick Dog

    RICKETTSIACEAE

  • (1) ROCKY MOUNTAIN SPOTTED FEVER

    caused by Rickettsia rickettsii

    most severe and most frequently reported rickettsial disease in

    the United States

    first recognized in 1896 in the Snake River Valley of Idaho and was originally

    called "black measles" because of the characteristic rash

    3-5% mortality (death may occur during the end of the second week due to kidney or heart failure)

    PRIMARY RESERVOIR: wild rodents

    VECTOR: hard ticks (Ixodes sp.); dog ticks (Dermacentor sp.)

    INCUBATION PERIOD: 7 days (range 2-14 days)

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (1) ROCKY MOUNTAIN SPOTTED FEVER

    VECTORS

    UNIQUE BACTERIA

    WOOD TICK

    (Dermacentorandersoni)

    DOG TICK

    (Dermacentorvariabilis)

    BROWN DOG TICK

    (Rhipicephalussanguineus)

    FEMALE LONE STAR TICK

    (Amblyommaamericanum)

    RICKETTSIAL DISEASES

  • (1) ROCKY MOUNTAIN SPOTTED FEVER

    CLINICAL MANIFESTATIONS:

    the classic triad of findings: fever, rash, and history of

    tick bite (rash fails to develop in 20% of cases)

    severe headache, muscle pain, nausea, vomiting,

    abdominal pain, and cough

    thrombocytopenia, anemia and hyponatremia

    WBC is typically normal

    lasts as long as 3 weeks

    COMPLICATIONS:

    CNS, cardiac, pulmonary, GI and renal involvement

    DIC > shock > death

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (1) ROCKY MOUNTAIN SPOTTED FEVER

    UNIQUE BACTERIARICKETTSIAL DISEASES

    appear first on the extremities

    Macule-

    painless, small (1-5 mm), flat non-itchy, faint pink

    in color

    moves centripetally 2-5 days after onset

    of illness

    Maculopapular-characteristic

    red, spotted rash on the 6th day

    Petechia and Purpura-

    hemorrhage in the center of the

    lesion

    2nd -5th day 6th day

  • (2) RICKETTSIALPOX

    caused by Rickettsia akari

    RESERVOIR: house mite (Mus musculus) & wild rodents

    VECTOR: mouse mite (Liponsyssoides sanguineus)

    INCUBATION PERIOD: 9-14 days

    non-communicable

    rarely associated with complications

    rare fatalities

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (2) RICKETTSIALPOX

    UNIQUE BACTERIARICKETTSIAL DISEASES

    Papuledevelopes at

    the site of the bite

    Papule ulcerates and forms a black Eschar (punched-out

    ulcer covered with blackened scab).

    Regional LN in the area becomes enlarged

    sudden onset of fever, chills, headache,

    vomiting, myalgia, anorexia, and photophobia

    generalized papulovesicular

    rash

    distributed centripetally

    rash will crust and heal without scarring

    First phase:

    1 week after the bite

    Second phase:

    2-3 days later 2-3 weeks later

  • (2) RICKETTSIALPOX

    UNIQUE BACTERIA

    HOUSE MOUSE

    (Mus musculus)

    MOUSE MITE

    (Liponyssoides sanguineus)

    VECTORRESERVOIR

    RICKETTSIAL DISEASES

  • (3) EPIDEMIC/LOUSE-BORNE TYPHUS

    caused by Rickettsia prowazekii

    occurs among people living in crowded, unsanitary

    conditions such as those found in wars, famine and

    natural disasters

    RESERVOIR: humans (primary), squirrel, fleas

    VECTOR: human body louse (Pediculus humanus corporis)

    INCUBATION PERIOD: 8 days

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (3) EPIDEMIC/LOUSE-BORNE TYPHUS

    UNIQUE BACTERIA

    FEMALE BODY LOUSE

    (Pediculus humanus corporis)

    VECTOR

    RICKETTSIAL DISEASES

  • (3) EPIDEMIC/LOUSE-BORNE TYPHUS

    CLINICAL SYNDROMES

    a. Epidemic typhus

    - is characterized by sudden onset of fever, chills, headache, myalgia and

    arthralgia.

    - after 4-7 days, maculopapular rash appears, becomes petechial or

    hemorrhagic, then develops brownish pigmented areas. Rashes spread

    centrifugally from the trunk first then spreads to the extremities (unlike the

    Spotted fever group)

    b. Brill-Zinsser disease

    - is recrudescent epidemic typhus. It occurs decades after the initial infection.- clinical course of the disease is similar to epidemic typhus but is milder and

    recovery is faster. The skin rash is rarely seen.- diagnosis is made on the basis of a fever with unknown origin and a history

    of previous exposure to epidemic typhus.

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (4) ENDEMIC/MURINE/FLEA-BORNE TYPHUS

    caused by Rickettsia typhi

    occurs worldwide

    RESERVOIR: Norway rat (Rattus norvegicus;); & cat flea

    VECTOR: rat flea (Xenopsylla cheopsis)

    INCUBATION PERIOD: 1-2 weeks

    CLINICAL SYNDROMES- fever, chills headache and myalgia.

    - macular or maculopapular rash appears on 4-7 days after onset of illness

    which begins on the trunk and spreads to the extremities (centrifugal

    spread), and lasts for 4-8 days. Rash remains discrete, with sparse lesions

    and no hemorrhage

    - disease is mild and resolves within 3 weeks even if untreated.

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (4) ENDEMIC/MURINE/FLEA-BORNE TYPHUs

    UNIQUE BACTERIA

    NORWAY RAT

    (Rattus norvegicus)

    RAT FLEA

    (Xenopsylla cheopsis)

    VECTORRESERVOIR

    RICKETTSIAL DISEASES

  • (5) SCRUB TYPHUS

    caused by Orientia (Rickettsia) tsutsugamushi

    occurs in Asia, Australia and the Pacific Islands

    RESERVOIR: mites and wild rodents

    VECTOR: chiggers, the larval form of a mite

    INCUBATION PERIOD: 1-3 weeks

    CLINICAL SYNDROMES- characterized by sudden onset of fever, chills headache and myalgia.

    - maculopapular rash develops 2 - 3 days later. The rash appears first on the

    trunk and spreads to the extremities (centrifugal spread).

    - also characterized by an eschar (50% of cases) at the inoculation bite.

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (6) Q FEVER

    caused by Coxiella burnetti

    resembles influenza, pneumonia, hepatitis or

    encephalopathy rather than typhus

    not characterized by rash and not transmitted by vector

    TRANSMISSION: inhalation of contaminated dust

    found in ticks, which transmit the bacteria to sheep, goats

    and cattle

    may develop infective endocarditis

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (7) HUMAN EHRLICHIOSIS

    DISEASES:

    a. Human Monocytotropic Ehrlichiosis (HME)

    - caused by Ehrlichia chaffeensis (in US) and Ehrlichia

    sennetsu (in Japan and Malaysia)

    b. Human Granulocytotropic Ehrlichiosis (HGE)

    - caused by Ehrlichia (Anaplasma) phagocytophilia and

    Ehrlichia ewingii

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (7) HUMAN EHRLICHIOSIS

    CLINICAL MANIFESTATION

    acute, systemic, febrile illnesses associated with headache, chills, malaise, myalgia, arthralgia, nausea, vomiting, anorexia and weight loss

    clinically similar to RMSF but differ in that infections often demonstrate the following:

    - leukopenia, absolute lymphopenia and neutropenia (HME)- neutropenia (HGE)- anemia- hepatitis- lack of vasculitis- rash less commonly

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • (7) HUMAN EHRLICHIOSIS

    COMPLICATIONS:

    - pulmonary, liver and kidney failure, bone marrow hypoplasia, encephalopathy, meningitis, DIC, spontaneous hemorrhage

    - anemia, hyponatremia, thrombocytopenia, transaminasemia

    VECTOR: tick vectors

    RESERVOIR: deer, mouse, dogs and other mammals

    INCUBATION PERIOD: 5-10 days after the tick bite and last

    for 1-2 weeks

    UNIQUE BACTERIARICKETTSIAL DISEASES

  • DIAGNOSIS

    - Clinical diagnosis:

    - Laboratory diagnosis:

    - culture of blood or CSF

    - direct detection after skin punch tissue biopsy: Giemsa stain

    Direct/indirect fluorescent antibody test (4-fold or greater change in antibody titer between acute and convalescent serum)

    - PCR

    - Weil-Felix test (agglutinate OX strains of Proteus vulgaris; no longer recommended)

    UNIQUE BACTERIA

    RICKETTSIACEAE

  • IFA reaction of a positive human serum on Rickettsia rickettsii grown in chicken yolk sacs

    Giemza stain of tick hemolymph cells infected with R. rickettsii

  • TREATMENT

    - antibiotic treatment should be initiated immediately

    - Doxycycline- Drug of choice

    - 100 mg every 12 hours for adults or 4 mg/kg body weight per day in two divided doses for

    children under 45 kg for a minimum total course of 5 to 10 days

    - Tetracyclines- contraindicated in pregnant women because of risks associated with malformation of teeth

    and bones in unborn children

    - Chloramphenicol- is an alternative drug

    UNIQUE BACTERIA

    RICKETTSIACEAE

  • PREVENTION

    prevention of tick bites

    - protective clothing, insect repellents, etc.

    tick control

    no vaccine is available

    UNIQUE BACTERIA

    RICKETTSIACEAE

  • THANK YOU

    INTRODUCTION TO IMMUNOLOGY